Reviewed by Michael Gill, B. Sc.
2 Sibo Clinical Trials Near Me
Top Hospitals for Sibo Clinical Trials
Image of Integrative Skin Science and Research in California.
Integrative Skin Science and Research
Sacramento
1Active Trials
0All Time Trials for Sibo
2022First Sibo Trial
Image of The New York Center for Travel and Tropical Medicine in New York.
The New York Center for Travel and Tropical Medicine
New York
1Active Trials
0All Time Trials for Sibo
2022First Sibo Trial
Top Cities for Sibo Clinical Trials
Image of Sacramento in California.
Sacramento
1Active Trials
Integrative Skin Science and ResearchTop Active Site
Image of New York in New York.
New York
1Active Trials
The New York Center for Travel and Tropical MedicineTop Active Site
Sibo Clinical Trials by Phase of Trial
Phase 2 Sibo Clinical Trials
1Active Sibo Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
Sibo Clinical Trials by Age Group
18+ Sibo Clinical Trials
1Active Sibo Clinical Trials
Most Recent Sibo Clinical Trials
Top Treatments for Sibo Clinical Trials
Treatment Name
Active Sibo Clinical Trials
All Time Trials for Sibo
First Recorded Sibo Trial
Olivirex
1
1
2021
AEMCOLO (Rifamycin SV MMX)
1
1
2020

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 7th, 2021

Last Reviewed: November 11th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003 Feb;98(2):412-9. https://pubmed.ncbi.nlm.nih.gov/125910622 Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, Schmulson M, Valdovinos M, Zakko S, Pimentel M. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017 May;112(5):775-784. doi: 10.1038/ajg.2017.46. Epub 2017 Mar 21. https://pubmed.ncbi.nlm.nih.gov/283232733 Furnari M, Parodi A, Gemignani L, Giannini EG, Marenco S, Savarino E, Assandri L, Fazio V, Bonfanti D, Inferrera S, Savarino V. Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010 Oct;32(8):1000-6. doi: 10.1111/j.1365-2036.2010.04436.x. Epub 2010 Aug 18. https://pubmed.ncbi.nlm.nih.gov/209370454 Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013 Oct;38(8):925-34. doi: 10.1111/apt.12479. Epub 2013 Sep 4. Review. https://pubmed.ncbi.nlm.nih.gov/240041015 Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007 Feb;3(2):112-22. https://pubmed.ncbi.nlm.nih.gov/219608206 Sachdev AH, Pimentel M. Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance. Ther Adv Chronic Dis. 2013 Sep;4(5):223-31. doi: 10.1177/2040622313496126. https://pubmed.ncbi.nlm.nih.gov/239979267 Quigley EM, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin North Am. 2010 Dec;24(4):943-59, viii-ix. doi: 10.1016/j.idc.2010.07.007. Review. https://pubmed.ncbi.nlm.nih.gov/209374598 Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017 Mar;45(5):604-616. doi: 10.1111/apt.13928. Epub 2017 Jan 12. Review. https://pubmed.ncbi.nlm.nih.gov/280787989 Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006 Jan-Feb;25(1):6-10. https://pubmed.ncbi.nlm.nih.gov/1656788610 Pimentel M, Chang C, Chua KS, Mirocha J, DiBaise J, Rao S, Amichai M. Antibiotic treatment of constipation-predominant irritable bowel syndrome. Dig Dis Sci. 2014 Jun;59(6):1278-85. doi: 10.1007/s10620-014-3157-8. Epub 2014 May 1. https://pubmed.ncbi.nlm.nih.gov/24788320